Solux Co. Ltd (290690) - Total Assets

Latest as of March 2026: ₩154.84 Billion KRW ≈ $104.93 Million USD

Based on the latest financial reports, Solux Co. Ltd (290690) holds total assets worth ₩154.84 Billion KRW (≈ $104.93 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Solux Co. Ltd - Total Assets Trend (2018–2025)

This chart illustrates how Solux Co. Ltd's total assets have evolved over time, based on quarterly financial data. Also see 290690 market cap for the company's overall valuation and market capitalisation.

Solux Co. Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Solux Co. Ltd's total assets of ₩154.84 Billion consist of 13.7% current assets and 86.4% non-current assets. Review total liabilities of Solux Co. Ltd to assess the company's total debt and financial obligations.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩0.00 0.4%
Accounts Receivable ₩10.90 Billion 7.7%
Inventory ₩2.25 Billion 1.6%
Property, Plant & Equipment ₩0.00 0.0%
Intangible Assets ₩934.60 Million 0.7%
Goodwill ₩0.00 0.0%

Asset Composition Trend (2018–2025)

This chart illustrates how Solux Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Solux Co. Ltd stock price today for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Solux Co. Ltd's current assets represent 13.7% of total assets in 2025, a decrease from 45.5% in 2018.
  • Cash Position: Cash and equivalents constituted 0.4% of total assets in 2025, up from 0.0% in 2018.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2018.
  • Asset Diversification: The largest asset category is accounts receivable at 7.7% of total assets.

Solux Co. Ltd Competitors by Total Assets

Key competitors of Solux Co. Ltd based on total assets are shown below.

Company Country Total Assets
ALK-Abelló A/S
CO:ALK-B
Denmark Dkr9.17 Billion
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
USA $890.92 Million
Xiamen Amoytop Biotech Co Ltd
SHG:688278
China CN¥3.21 Billion
BB Biotech AG
SW:BION
Switzerland CHF3.09 Billion
Soleno Therapeutics Inc
NASDAQ:SLNO
USA $608.39 Million
Nanobiotix
NASDAQ:NBTX
USA $67.76 Million
Inhibrx Biosciences, Inc.
NASDAQ:INBX
USA $183.97 Million
Wuhan Keqian Biology Co Ltd
SHG:688526
China CN¥4.75 Billion

Solux Co. Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.59 0.86 1.77
Quick Ratio 0.54 0.77 1.56
Cash Ratio 0.00 0.02 0.04
Working Capital ₩-26.18 Billion ₩-5.48 Billion ₩14.45 Billion

Solux Co. Ltd - Advanced Valuation Insights

This section examines the relationship between Solux Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.48
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 20.7%
Total Assets ₩141.59 Billion
Market Capitalization $131.72 Million USD

Valuation Analysis

Below Book Valuation: The market values Solux Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Solux Co. Ltd's assets grew by 20.7% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Solux Co. Ltd (2018–2025)

The table below shows the annual total assets of Solux Co. Ltd from 2018 to 2025.

Year Total Assets Change
2025-12-31 ₩141.59 Billion
≈ $95.95 Million
+20.71%
2024-12-31 ₩117.30 Billion
≈ $79.49 Million
-26.76%
2023-12-31 ₩160.17 Billion
≈ $108.54 Million
+134.13%
2022-12-31 ₩68.41 Billion
≈ $46.36 Million
-7.40%
2021-12-31 ₩73.88 Billion
≈ $50.07 Million
+10.98%
2020-12-31 ₩66.57 Billion
≈ $45.11 Million
+38.03%
2019-12-31 ₩48.23 Billion
≈ $32.68 Million
+10.19%
2018-12-31 ₩43.77 Billion
≈ $29.66 Million
--

About Solux Co. Ltd

KQ:290690 Korea Biotechnology
Market Cap
$131.72 Million
₩194.37 Billion KRW
Market Cap Rank
#18228 Global
#805 in Korea
Share Price
₩3940.00
Change (1 day)
-0.51%
52-Week Range
₩2720.00 - ₩6020.00
All Time High
₩34400.00
About

ARIBIO Holdings Inc. manufactures and supplies indoor, outdoor, and special purpose lighting products in South Korea and internationally. The company was formerly known as Solux Co., Ltd. and changed its name to ARIBIO Holdings Inc. in July 2026. ARIBIO Holdings Inc. was founded in 1995 and is headquartered in Gongju-si, South Korea.